Concepedia

Yumei Ye

YY

Statistics

Publications

68

Citations

4.4K

H-Index

35

Active since

2001

Affiliations

The University of Texas Medical Branch at Galveston(Current)

Baylor College of Medicine

First Affiliated Hospital of Kunming Medical University

Kunming Medical University

AstraZeneca (Sweden)

Yumei Ye is an author at The University of Texas Medical Branch at Galveston specializing in pharmacology, medicine, and cardiology.

Publications per year

2001–2023

68

Publications

68

Antibody-Drug Conjugates Designed to Eradicate Tumors with Homogeneous and Heterogeneous Expression of the Target Antigen

Yelena Kovtun, Charlene A. Audette, Yumei Ye et al. · Cancer Research · 2006 · 474 citations · Full text

Pharmacy, Oncology, Pharmacology +17

SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor

Yumei Ye, Mandeep Bajaj, Hsiu‐Chiung Yang et al. · Cardiovascular Drugs and Therapy · 2017 · 366 citations

Medicine, Pharmacology, Pharmacotherapy +17

Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γ agonist protects against myocardial ischaemia–reperfusion injury

Yumei Ye, Zhaoyong Hu, Yu Lin et al. · Cardiovascular Research · 2010 · 201 citations

Life Sciences, Cardiology, Pharmacology +16

Augmentation of Myocardial Production of 15-Epi-Lipoxin-A <sub>4</sub> by Pioglitazone and Atorvastatin in the Rat

Yochai Birnbaum, Yumei Ye, Yu Lin et al. · Circulation · 2006 · 169 citations · Full text

Medicine, Cardiology, Pharmacology +14

The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA

Yumei Ye, Kyle T. Keyes, Congfang Zhang et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2010 · 151 citations

Medicine, Cardiology, Pharmacology +16

1–5 of 68